Multicenter Adaptive Randomized Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections(STRIVE)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Covid-19
-
Age: Between 18 Year(s) - 99 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Confirmation of SARS-CoV-2 infection within the prior 14 days.
- Onset of symptoms attributable to SARS-CoV-2 infection occurred within 14 days before randomization.
- Hospitalized for the management of COVID-19, with signs and/or symptoms suggestive of lower respiratory tract infection.
You may not be eligible for this study if the following are true:
-
- Moderate to severe hepatic impairment or acute liver failure.
- Known estimated glomerular filtration rate (eGRF) <30 mL/min/1.73m2
- Continuous renal replacement therapy or chronic dialysis
- Current pregnancy
- Current breastfeeding and unwillingness to defer breastfeeding for 30 days after the last dose of investigational agent.
- Women of child-bearing potential who are unwilling to abstain from sexual intercourse with men or practice appropriate contraception through 30 days from the last dose of the investigational agent.
- Men who are unwilling to abstain from sexual intercourse with women of child-bearing potential or to use barrier contraception through 30 days from the last dose of the investigational agent
- Inability to take investigational agent in tablet form by mouth.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.